Neuralink's Blindsight AI Implant Receives FDA Breakthrough Status for Vision Restoration

Thumbnail Image

The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.

Elon Musk's Neuralink announced its AI-powered Blindsight brain implant, designed to restore vision even for those blind from birth or without optic nerves, has received the FDA's 'breakthrough device' designation. The device is experimental, with no reported harm, and aims to enable future human trials.[AI generated]

Why's our monitor labelling this an incident or hazard?

The event involves an AI system (Neuralink's brain-chip with AI capabilities) designed to restore vision by interfacing with the brain's visual cortex. Although no direct harm is reported yet, the invasive nature and experimental status imply plausible future risks of injury or health harm if the system malfunctions or is misused. Therefore, this qualifies as an AI Hazard due to the credible potential for harm in the future.[AI generated]
AI principles
SafetyRobustness & digital securityPrivacy & data governanceRespect of human rightsTransparency & explainabilityAccountabilityFairnessHuman wellbeingDemocracy & human autonomy

Industries
Healthcare, drugs, and biotechnologyRobots, sensors, and IT hardwareDigital securityIT infrastructure and hosting

Harm types
Physical (injury)Physical (death)PsychologicalHuman or fundamental rightsReputationalEconomic/PropertyPublic interest

Business function:
Research and development

AI system task:
Recognition/object detectionContent generationReasoning with knowledge structures/planning


Articles about this incident or hazard